ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 3061 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 3061; 2) Community: the network communities that were significantly associated with the response to NSC 3061; 3) Molecule: the relationships between components within communities and NSC 3061; 4) MDR: the compounds that were significantly associated with the NSC 3061.

NSC Compound Enrichment Correlation
NSC 128687 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) 0.000104553642000969 0.49943086
NSC 757113 METHOTREXATE(+/-) 0.00010455364200097 0.59946575
NSC 174121 Methotrexate Derivative 0.000141616984257996 0.6798128
NSC 666783 Pyrido[2,3-d]pyrimidine-2,4-diamine, 6-[[(4-methoxy- phenyl)amino]methyl]-5-methyl-, 3/5 methanol 0.000141616984257996 0.73349317
NSC 368390 Brequinar 0.000150163566228975 0.67002984
NSC 650025 Null 0.000150163566228975 0.35480669
NSC 716260 Null 0.000150163566228975 0.39894237
NSC 326408 Rocaglamide (FR AGLAIA ELLIPTIFOLIA) 0.000152553454647255 0.54075074
NSC 709974 Null 0.000152553454647255 0.48671905
NSC 303812 Aphidicoline glycinate 0.000166573147098352 0.5905992
Total:78  Current:1    [First] [Prev] [Next] [Last]